Taro Pharmaceutical
TARO
$42.48
Share price
0.66%
Change (1 day)
66.20%
Change (1 year)
Categories
Operating Margin for Taro Pharmaceutical (TARO)
Operating Margin as of April 2024 (TTM): 13.86%
According to Taro Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 13.86%. At the end of 2022 the company had an Operating Margin of 13.87%.
Operating Margin history for Taro Pharmaceutical from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 13.87% | -119.47% |
| 2021 | -71.24% | -254.12% |
| 2020 | 46.22% | -13.23% |
| 2019 | 53.27% | 20.6% |
| 2018 | 44.17% | -30.74% |
| 2017 | 63.77% | -4.79% |
| 2016 | 66.98% | -0.63% |
| 2015 | 67.41% | 15.3% |
| 2014 | 58.46% | 16.79% |
| 2013 | 50.06% | 12.83% |
| 2012 | 44.36% | 7.72% |
| 2011 | 41.19% | 114.47% |
| 2010 | 19.20% | 45.84% |
| 2009 | 13.17% | -1.67% |
| 2008 | 13.39% | 5.53% |
| 2007 | 12.69% | -139.13% |
| 2006 | -32.43% | -1423.74% |
| 2005 | 2.45% | -200.4% |
| 2004 | -2.44% | -110.55% |
| 2003 | 23.13% | -7.61% |
| 2002 | 25.03% | 23.73% |
| 2001 | 20.23% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 65.08% | 🇺🇸 USA |
 Novartis NVS | 17.27% | 24.60% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | 149.71% | 🇺🇸 USA |
 Merck MRK | 27.73% | 100.07% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | 62.63% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -20.53% | -248.12% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.